Ma X, Liu B, Jiang Z, Rao Z, Zheng L
Int J Mol Sci. 2025; 26(1.
PMID: 39796197
PMC: 11720236.
DOI: 10.3390/ijms26010343.
Guo J, Cao Y, Wu Q, Cen L
World J Diabetes. 2024; 15(10):2002-2005.
PMID: 39493566
PMC: 11525723.
DOI: 10.4239/wjd.v15.i10.2002.
Zhao X, Zhang J, Xu F, Shang L, Liu Q, Shen C
Open Life Sci. 2024; 19(1):20220957.
PMID: 39290498
PMC: 11406225.
DOI: 10.1515/biol-2022-0957.
Song K, Liang D, Xiao D, Kang A, Ren Y
Mol Med Rep. 2024; 30(5).
PMID: 39239741
PMC: 11411234.
DOI: 10.3892/mmr.2024.13323.
Li W, Liu X, Liu Z, Xing Q, Liu R, Wu Q
Front Pharmacol. 2024; 15:1416403.
PMID: 39021834
PMC: 11251973.
DOI: 10.3389/fphar.2024.1416403.
Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy.
Mahmoud L, Mageed A, Saadallah J, Youssef M, Rashed L, Ammar H
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):8023-8041.
PMID: 38775851
PMC: 11450109.
DOI: 10.1007/s00210-024-03152-1.
NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies.
Rezaee A, Rahmanian P, Nemati A, Sohrabifard F, Karimi F, Elahinia A
Heliyon. 2024; 10(9):e29871.
PMID: 38707342
PMC: 11066643.
DOI: 10.1016/j.heliyon.2024.e29871.
NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention.
Ding P, Song Y, Yang Y, Zeng C
Front Pharmacol. 2024; 15:1368835.
PMID: 38681198
PMC: 11045953.
DOI: 10.3389/fphar.2024.1368835.
Diabetic Cardiomyopathy-From Basics through Diagnosis to Treatment.
Radzioch E, Dabek B, Balcerczyk-Lis M, Frak W, Fularski P, Mlynarska E
Biomedicines. 2024; 12(4).
PMID: 38672121
PMC: 11048005.
DOI: 10.3390/biomedicines12040765.
LncRNA and mRNA expression characteristic and bioinformatic analysis in myocardium of diabetic cardiomyopathy mice.
Zhao M, Wang T, Cai X, Li G, Li N, Zhou H
BMC Genomics. 2024; 25(1):312.
PMID: 38532337
PMC: 10967189.
DOI: 10.1186/s12864-024-10235-z.
ATP releasing channels and the ameliorative effects of high intensity interval training on diabetic heart: a multifaceted analysis.
Joukar S, Rajizadeh M, Bejeshk M, Alavi S, Bagheri F, Rami M
Sci Rep. 2024; 14(1):7113.
PMID: 38532054
PMC: 10965991.
DOI: 10.1038/s41598-024-57818-0.
Diabetic cardiomyopathy in rats was attenuated by endurance exercise through the inhibition of inflammation and apoptosis.
Shabab S, Mahmoudabady M, Gholamnezhad Z, Fouladi M, Asghari A
Heliyon. 2024; 10(1):e23427.
PMID: 38163155
PMC: 10757033.
DOI: 10.1016/j.heliyon.2023.e23427.
Protective Effect of Topiramate against Diabetic Retinopathy and Computational Approach Recognizing the Role of NLRP3/IL-1β/TNF-α Signaling.
Mohammad H, Eladl M, AbdelMaogood A, Elshaer R, Ghanam W, Elaskary A
Biomedicines. 2023; 11(12).
PMID: 38137423
PMC: 10741203.
DOI: 10.3390/biomedicines11123202.
Moderate- and High-Intensity Endurance Training Alleviate Diabetes-Induced Cardiac Dysfunction in Rats.
DHaese S, Verboven M, Evens L, Deluyker D, Lambrichts I, Eijnde B
Nutrients. 2023; 15(18).
PMID: 37764732
PMC: 10535416.
DOI: 10.3390/nu15183950.
Physical Activity as a Modern Intervention in the Fight against Obesity-Related Inflammation in Type 2 Diabetes Mellitus and Gestational Diabetes.
Piotrowska K, Zgutka K, Tkacz M, Tarnowski M
Antioxidants (Basel). 2023; 12(8).
PMID: 37627482
PMC: 10451679.
DOI: 10.3390/antiox12081488.
Rhein alleviates advanced glycation end products (AGEs)-induced inflammatory injury of diabetic cardiomyopathy in vitro and in vivo models.
Zhao S, Zhao H, Wang B, Shao C, Pan W, Li S
J Nat Med. 2023; 77(4):898-915.
PMID: 37598111
DOI: 10.1007/s11418-023-01741-7.
Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions.
Huo J, Feng Q, Pan S, Fu W, Liu Z, Liu Z
Cell Death Discov. 2023; 9(1):256.
PMID: 37479697
PMC: 10362058.
DOI: 10.1038/s41420-023-01553-4.
Analysis of Signaling Pathways of Necroptotic and Pyroptotic Cell Death in the Hearts of Rats With Type 2 Diabetes Mellitus.
Horvath C, Jarabicova I, Rajtik T, Bartosova L, Ferenczyova K, Kalocayova B
Physiol Res. 2023; 72(S1):S23-S29.
PMID: 37294115
PMC: 10292816.
DOI: 10.33549/physiolres.935020.
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets.
Tanase D, Valasciuc E, Gosav E, Ouatu A, Buliga-Finis O, Floria M
Int J Mol Sci. 2023; 24(9).
PMID: 37175869
PMC: 10179095.
DOI: 10.3390/ijms24098162.
The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes.
Zhang L, Liu H, Li F, Yang F, Qian L, Wang R
J Inflamm Res. 2023; 15:6883-6889.
PMID: 36600995
PMC: 9807127.
DOI: 10.2147/JIR.S390310.